Wen Jiang

发表

A New Strategy to Rapidly Evaluate Kinetics of Glucuronide Efflux by Breast Cancer Resistance Protein (BCRP/ABCG2)

Taijun Yin, Song Gao, M. Hu, 2012, Pharmaceutical Research.

Breast Cancer Resistance Protein-Mediated Efflux of Luteolin Glucuronides in HeLa Cells Overexpressing UDP-Glucuronosyltransferase 1A9

M. Hu, Zhongqiu Liu, Wen Jiang, 2013, Pharmaceutical Research.

The discovery of purine-based agents targeting triple-negative breast cancer and the αB-crystallin/VEGF protein–protein interaction

A. Brancale, A. Westwell, Wen Jiang, 2018, Medicinal Chemistry Research.

Response to Letter to the Editor on “Breast Cancer Resistance Protein (ABCG2) Determines Distribution of Genistein Phase II Metabolites: Reevaluation of the Roles of ABCG2 in the Disposition of Genistein”

Taijun Yin, Song Gao, M. Hu, 2012, Drug Metabolism and Disposition.

Mutual interactions between flavonoids and enzymatic and transporter elements responsible for flavonoid disposition via phase II metabolic pathways.

M. Hu, Wen Jiang, Ming Hu, 2012, RSC advances.

UGT1A9-overexpressing HeLa Cells Is an Appropriate Tool to Delineate the Kinetic Interplay between BCRP and UGT and to Rapidly Identify the Glucuronide Substrates of BCRP

Baojian Wu, Wen Jiang, Minghui Hu, 2011 .

Tankyrase disrupts metabolic homeostasis and promotes tumorigenesis by inhibiting LKB1-AMPK signalling

Rui Ye, Steven H. Lin, M. Hung, 2019, Nature Communications.

UDP-Glucuronosyltransferase (UGT) 1A9-Overexpressing HeLa Cells Is an Appropriate Tool to Delineate the Kinetic Interplay between Breast Cancer Resistance Protein (BRCP) and UGT and to Rapidly Identify the Glucuronide Substrates of BCRP

Baojian Wu, Ming Hu, Wen Jiang, 2012, Drug Metabolism and Disposition.

Repurposing old carbon monoxide-releasing molecules towards the anti-angiogenic therapy of triple-negative breast cancer

A. Westwell, Wen Jiang, Jun Cai, 2019, Oncotarget.

Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression

A. Nel, F. Salazar, A. Wu, 2017, Nature Communications.

Breast Cancer Resistance Protein (ABCG2) Determines Distribution of Genistein Phase II Metabolites: Reevaluation of the Roles of ABCG2 in the Disposition of Genistein

Taijun Yin, Song Gao, Wen Jiang, 2012, Drug Metabolism and Disposition.

Highly variable contents of phenolics in St. John's Wort products affect their transport in the human intestinal Caco-2 cell model: pharmaceutical and biopharmaceutical rationale for product standardization.

Taijun Yin, Song Gao, Wen Jiang, 2010, Journal of agricultural and food chemistry.

Revolving door action of breast cancer resistance protein (BCRP) facilitates or controls the efflux of flavone glucuronides from UGT1A9-overexpressing HeLa cells.

S. Basu, X. Jia, Taijun Yin, 2013, Molecular pharmaceutics.

A New Strategy to Rapidly Evaluate Kinetics of Glucuronide Efflux by Breast Cancer Resistance Protein (BCRP/ABCG2)

Taijun Yin, Song Gao, Baojian Wu, 2012, Pharmaceutical Research.

Breast Cancer Resistance Protein-Mediated Efflux of Luteolin Glucuronides in HeLa Cells Overexpressing UDP-Glucuronosyltransferase 1A9

Zhongqiu Liu, Wen Jiang, Lan Tang, 2014, Pharmaceutical Research.

MIF/CD74 axis is a target for metformin therapy in diabetic podocytopathy - real world evidence.

Wen Jiang, S. Ye, Yan Chen, 2018, Endokrynologia Polska.

Structural modifications on CORM-3 lead to enhanced anti-angiogenic properties against triple-negative breast cancer cells.

A. Westwell, Wen Jiang, Jun Cai, 2019, Medicinal chemistry (Shariqah (United Arab Emirates)).